Thioredoxin Reductase 1/TRXR1 Antibody (30F1) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-59489F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # 30F1
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human Thioredoxin Reductase 1/TRXR1 (161-647aa) purified from E. coli
Reactivity Notes
0
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for Thioredoxin Reductase 1/TRXR1 Antibody (30F1) [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Thioredoxin Reductase 1/TRXR1
Alternate Names
GRIM-12, KDRF, TR1, TRXR1, TRXRD1, TXNR, TXNRD1
Gene Symbol
TXNRD1
Additional Thioredoxin Reductase 1/TRXR1 Products
Product Documents for Thioredoxin Reductase 1/TRXR1 Antibody (30F1) [FITC]
Product Specific Notices for Thioredoxin Reductase 1/TRXR1 Antibody (30F1) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...